50411-26-2 Usage
General Description
1-AMINO-3-PHENYL-PROPAN-2-OL, also known as phenylpropanolamine, is a synthetic compound that is commonly used as a decongestant and appetite suppressant. It works by constricting blood vessels in the nasal passages, which helps to relieve congestion and improve breathing. It is also believed to stimulate the central nervous system, which can lead to decreased appetite. However, its use has been associated with an increased risk of stroke, and it has been banned in many countries due to safety concerns. In addition to its pharmaceutical uses, 1-AMINO-3-PHENYL-PROPAN-2-OL has also been studied for potential applications in the treatment of neurodegenerative diseases and as an intermediate in organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 50411-26-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,4,1 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 50411-26:
(7*5)+(6*0)+(5*4)+(4*1)+(3*1)+(2*2)+(1*6)=72
72 % 10 = 2
So 50411-26-2 is a valid CAS Registry Number.
50411-26-2Relevant articles and documents
PYRAZOLOPYRAZINES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE
-
Page/Page column 42; 43, (2017/04/11)
The present invention relates to a compound having the general formula (IIa) or (IIb), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph,codrug, cocrystal,prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 35, (2008/12/08)
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 72, (2008/12/08)
-